Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days to Obtain Report for RAS Extended Profiling Analysis Test by NGS

The report for the RAS Extended Profiling Analysis Test by NGS can typically be obtained within 7-10 business days after the sample is received by the laboratory.

What are the prerequisites for the test RAS Extended Profiling Analysis Test by NGS

  • Sample type: FFPE tissue block or FFPE slide
  • Sample size: Minimum of 10% tumor content
  • Sample quality: RNA Integrity Number (RIN) ≥ 7.0
  • Sample quantity: Minimum of 200 ng of total RNA
  • Turnaround time: 7-10 business days

What are the measure values for the test RAS Extended Profiling Analysis Test by NGS

  • Measure 1: KRAS G12C Mutation Frequency
  • Measure 2: KRAS G12D Mutation Frequency
  • Measure 3: KRAS G12V Mutation Frequency
  • Measure 4: KRAS G13D Mutation Frequency
  • Measure 5: KRAS Q61H Mutation Frequency

What does this test RAS Extended Profiling Analysis Test by NGS identify?

RAS Extended Profiling Analysis Test

The RAS Extended Profiling Analysis Test by NGS is a diagnostic test that identifies mutations in RAS genes. RAS genes are a group of genes that encode proteins involved in cell signaling pathways. Mutations in these genes can lead to uncontrolled cell growth and division, contributing to the development of various cancers.

This test uses Next Generation Sequencing (NGS) technology to analyze the DNA of a patient and detect mutations in specific regions of RAS genes. The results of this test can help determine the potential effectiveness of targeted therapies that specifically target RAS-mutant cancers.

Why is this test RAS Extended Profiling Analysis Test by NGS taken?

The RAS Extended Profiling Analysis Test by NGS is taken to identify mutations in RAS genes that can help guide treatment decisions for patients with certain types of cancer, such as colorectal cancer. Mutations in RAS genes can affect how well certain targeted therapies, like anti-EGFR drugs, work in treating cancer.

By analyzing the RAS genes using NGS (Next-Generation Sequencing) technology, this test can provide detailed information about specific mutations present in the tumor, allowing healthcare providers to personalize treatment plans based on the genetic profile of the cancer.

Overall, the RAS Extended Profiling Analysis Test by NGS is an important tool in precision medicine, helping to tailor therapy to individual patients based on their unique genetic makeup.

No FAQs available.

Customer Google Rating